维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01873 维亚生物

未开盘 06-10 16:09:07

1.150

+0.000

0.00%

最高1.150	最低1.080	成交量403.75万
今开1.080	昨收1.150	日振幅6.09%
总市值24.50亿	流通市值24.50亿	总股本21.30亿
成交额451.31万	换手率0.19%	流通股本21.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01873","market":"HK","secType":"STK","nameCN":"维亚生物","latestPrice":1.15,"timestamp":1781078947003,"preClose":1.15,"halted":0,"volume":4037500,"delay":0,"changeRate":0,"floatShares":2130000000,"shares":2130000000,"eps":0.10401868279991223,"marketStatus":"未开盘","change":0,"latestTime":"06-10 16:09:07","open":1.08,"high":1.15,"low":1.08,"amount":4513100,"amplitude":0.06087,"askPrice":1.15,"askSize":122500,"bidPrice":1.13,"bidSize":226000,"shortable":3,"etf":0,"ttmEps":0.13175699821322218,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781141400000},"marketStatusCode":0,"adr":0,"listingDate":1557331200000,"exchange":"SEHK","adjPreClose":1.15,"openAndCloseTimeList":[[1781055000000,1781064000000],[1781067600000,1781078400000]],"volumeRatio":0.4743289194403116,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01873/","defaultTab":"news","newsList":[{"id":"1165955368","title":"维亚生物6月10日回购78.25万股股份，总额约89.32万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165955368","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165955368?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:26","pubTimestamp":1781087188,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年6月10日发布公告，披露该公司当日在香港联交所场内回购股份78.25万股，占回购授权决议获通过当日已发行股本的约0.0367%。本次回购每股价格介乎港币1.13元至1.15元，总耗资约89.32万港元。回购完成后，因相关股份暂未注销，2026年6月10日的已发行股本仍为21.29882353亿股，库藏股份仍为0股。根据公告，维亚生物科技控股集团于2025年6月12日通过了购回授权，授权可购回股份总数为2.1284343亿股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维亚生物6月10日回购78.25万股股份，总额约89.32万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447706","title":"维亚生物(01873)6月10日斥资89.32万港元回购78.25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447706","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642447706?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:21","pubTimestamp":1781086893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，于2026年6月10日斥资89.32万港元回购78.25万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01873","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178423690","title":"维亚生物6月9日回购69.30万股，耗资约79.10万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178423690","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178423690?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:17","pubTimestamp":1781000250,"startTime":"0","endTime":"0","summary":"2026年6月9日，维亚生物科技控股集团发布公告称，当日于香港联交所回购普通股69.30万股，占此前已发行股本约0.0325%。本次回购价格区间为每股1.13港元至1.15港元，合计耗资约79.10万港元。回购完成后，公司已发行股本数量维持在2,129,882,353股，库藏股数量仍为0股。公告显示，公司于2025年6月12日通过股份购回授权，总回购额度为212,843,430股，迄今已在包括香港联交所等证券交易所合计回购26,910,500股，占授权当日公司已发行股本的约1.2643%。本公告由公司执行董事毛晨签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维亚生物6月9日回购69.30万股，耗资约79.10万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116030432","title":"维亚生物：6月8日回购90万股，耗资约102.90万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116030432","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116030432?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:31","pubTimestamp":1780914712,"startTime":"0","endTime":"0","summary":"维亚生物于2026年6月8日发布翌日披露报表，公告显示，公司当日在香港联交所场内回购普通股合计900,000股，占回购前已发行股本约0.0423%。本次回购的每股最高价为1.15港元，最低价为1.14港元，合计耗资约102.90万港元。购回授权于2025年6月12日经股东大会批准，维亚生物可依据该授权回购最多212,843,430股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物：6月8日回购90万股，耗资约102.90万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485300","title":"维亚生物(01873)6月8日斥资102.9万港元回购90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485300","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641485300?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:28","pubTimestamp":1780914517,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，于2026年6月8日，该公司斥资102.9万港元回购90万股股份，每股回购价1.14-1.15港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示，2026年第一季度，海外CXO行业整体呈现分化复苏格局，全球生物制药融资环境出现实质性改善，带动需求逐步回暖，但早期初创企业资金压力仍未完全缓解，不同细分赛道、不同规模企业的表现存在差异，行业结构性分化特征进一步凸显。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","06127","BK1515","BK1191","LU0708995583.HKD","09939","BK1141","HK0000320223.HKD","LU1046422090.SGD","LU0856984785.SGD","HK0000320264.USD","LU2045819591.USD","02359","LU0348735423.USD","LU0417516902.SGD","LU0572944931.SGD","LU0516422952.EUR","01548","LU1720050803.USD","LU0140636845.USD","LU2242644610.SGD","BK1521","LU2039709279.SGD","03347","LU0320764599.SGD","06821","LU0348767384.USD","LU0326950275.SGD","LU0417516738.SGD","LU1880383366.USD","LU0456827905.SGD","159938","LU0307460666.USD","01521","02269","LU3063872942.SGD","LU0588546209.SGD","BK1574","01873","HK0000306685.HKD","LU0516423091.SGD","03759","LU0039217434.USD","LU0516422440.USD","SG9999002463.SGD","LU1688375341.USD","LU0359201612.USD","LU0516422366.SGD","BK1589","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111158","title":"维亚生物(01873)6月5日斥资314.35万港元回购260万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111158","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641111158?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:51","pubTimestamp":1780653071,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，该公司于2026年6月5日斥资314.35万港元回购260万股股份，每股回购价格为1.19-1.22港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450776.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182317588","title":"维亚生物回购260万股股份，耗资约314.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182317588","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182317588?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:48","pubTimestamp":1780652911,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年6月5日公告，按购回计划在香港联合交易所场内回购2,600,000股普通股，占公司已发行股本约0.1221%。每股回购价介乎港币1.19元至1.22元，合计耗资约港币3,143,540元。本次回购完成后，公司已发行股本仍为2,129,882,353股，库藏股截至公告日未发生结余变化。根据公告，公司于2025年6月12日获股东大会通过回购授权，可最多回购212,843,430股；目前公司已累计回购25,317,500股，占授权通过当日已发行股本约1.1895%。公告由公司执行董事毛晨签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物回购260万股股份，耗资约314.35万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176582289","title":"维亚生物6月4日回购110万股，涉资约136.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176582289","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176582289?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:22","pubTimestamp":1780568535,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团（股票代码：01873）于2026年6月4日发布翌日披露报表，公告当日回购普通股共110万股，约占公司现有已发行股本的0.0516%。回购价介乎每股1.22港元至1.26港元，合计支付约136.15万港元。截至当日，公司已发行股本总数仍为2,129,882,353股，库藏股数为0股。\n根据公告，回购授权于2025年6月12日通过，公司可回购的总股数为212,843,430股，迄今已在香港联交所及其他交易所合计回购22,717,500股，占授权通过当日已发行股本总数约1.0673%。公司确认已遵守香港联交所证券上市规则及相关法律法规。公告由执行董事毛晨签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物6月4日回购110万股，涉资约136.15万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189616911","title":"维亚生物回购147.8万股股份，总额约182.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189616911","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189616911?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:22","pubTimestamp":1780482130,"startTime":"0","endTime":"0","summary":"维亚生物(01873)于2026年6月3日发布公告称，当日在香港联交所场内回购147.8万股普通股股份，占已发行股本约0.0694%。本次回购每股价格介乎1.22港元至1.26港元，合计涉资约182.35万港元，所购回股份尚未注销。\n自2025年6月12日相关购回授权获批以来，公司已累计购回21,617,500股，占授权通过当日已发行股本的1.0157%。目前已发行股本总数为2,129,882,353股，购回授权下可回购的剩余额度为191,225,930股。公告同时确认已遵守香港联合交易所有限公司的上市规则及相关法律规定。本次公告由执行董事毛晨签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物回购147.8万股股份，总额约182.35万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090304","title":"维亚生物(01873)6月3日耗资182.35万港元回购147.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090304","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640090304?lang=zh_cn&edition=full","pubTime":"2026-06-03 18:20","pubTimestamp":1780482039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)公布，2026年6月3日耗资182.35万港元回购147.8万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111535363","title":"维亚生物6月1日回购20.05万股，耗资约25.66万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111535363","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111535363?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:16","pubTimestamp":1780312560,"startTime":"0","endTime":"0","summary":"维亚生物于2026年6月1日发布公告称，公司于当日在香港联交所场内回购普通股200,500股，占本次交易日前公司已发行股本总数2,129,882,353股的约0.0094%。回购价格为每股港币1.28元，合计耗资约25.66万港元。公告显示，本次股份回购基于公司于2025年6月12日通过的股份回购授权，授权购回股份上限为212,843,430股；截至目前，维亚生物已累计回购20,139,500股，约占该授权通过当日已发行股本的0.9462%。公司同时确认已遵守相关上市规则和法律法规。公告由执行董事毛晨签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物6月1日回购20.05万股，耗资约25.66万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640956329","title":"维亚生物(01873)6月1日斥资25.66万港元回购20.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640956329","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640956329?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:14","pubTimestamp":1780312490,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，于2026年6月1日斥资25.66万港元回购20.05万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01873","BK1141","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182623691","title":"维亚生物5月29日回购82.05万股股份，总额约102.17万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1182623691","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182623691?lang=zh_cn&edition=full","pubTime":"2026-05-29 18:38","pubTimestamp":1780051114,"startTime":"0","endTime":"0","summary":"维亚生物于2026年5月29日发布的翌日披露报表显示，公司当日于香港联交所场内回购普通股820,500股，占现有已发行股本约0.0385%。此次回购价格介乎每股港币1.23元至1.26元，合共支付约102.17万港元。根据公告披露，截至2026年5月29日，公司已发行股本为2,129,882,353股，库藏股数为0股。该批回购股份拟予注销，但于公告期末尚未注销。公告同时显示，本次回购基于公司于2025年6月12日获通过的购回授权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物5月29日回购82.05万股股份，总额约102.17万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639001629","title":"维亚生物(01873)5月29日斥资102.17万港元回购82.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639001629","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639001629?lang=zh_cn&edition=full","pubTime":"2026-05-29 18:33","pubTimestamp":1780050827,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，该公司于2026年5月29日斥资102.17万港元回购82.05万股股份，每股回购价格为1.23-1.26港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158929793","title":"维亚生物5月28日回购390万股，涉资约489.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158929793","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158929793?lang=zh_cn&edition=full","pubTime":"2026-05-28 18:32","pubTimestamp":1779964367,"startTime":"0","endTime":"0","summary":"2026年5月28日，维亚生物在港交所发布翌日披露报表，公告显示，公司于当日在香港联交所场内回购合共3,900,000股普通股，约占当日现有已发行股本的0.1831%。回购价格介乎每股1.25港元至1.26港元，合计支付约489.50万港元。公告同时披露，维亚生物因回购而尚未注销的股份自今年5月8日起持续增至5月28日当日，累计购回股份数目已达19,118,500股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物5月28日回购390万股，涉资约489.50万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121771822","title":"维亚生物：5月27日回购60万股，耗资约80.25万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121771822","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121771822?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:02","pubTimestamp":1779879731,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于5月27日发布公告，披露该公司在香港联交所场内进行股份回购，共计回购60万股普通股，约占已发行股本的0.0282%，回购价格介乎每股港币1.33元至1.34元，总耗资约80.25万港元。公告显示，自5月8日至5月27日期间，公司已根据购回授权累计回购约1,521.85万股股份，占购回授权通过当日已发行股本的0.715%。该购回授权于6月12日获股东大会通过，允许公司最多回购2.1284343亿股。公司确认所有回购行为均已遵守上市规则及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物：5月27日回购60万股，耗资约80.25万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638588504","title":"维亚生物(01873)5月27日斥资80.25万港元回购60万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638588504","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638588504?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:00","pubTimestamp":1779879625,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，于2026年5月27日该公司斥资80.25万港元回购60万股，回购价格为每股1.33-1.34港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","01873","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108067587","title":"维亚生物5月26日回购70.85万股，耗资约97.88万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108067587","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108067587?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:42","pubTimestamp":1779792156,"startTime":"0","endTime":"0","summary":"维亚生物科技控股集团于2026年5月26日发布翌日披露报表。公告显示，公司当日在香港联交所场内回购普通股708,500股，占回购前公司已发行股份的约0.0333%，每股回购价介乎1.37港元至1.39港元，合计耗资978,815港元，相关回购股份尚未注销。公司表示，截至本次回购后，于2026年5月26日已发行股本为2,129,882,353股，现时无库存股份。根据股东于2025年6月12日通过的购回授权，公司可回购股份总数为212,843,430股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物5月26日回购70.85万股，耗资约97.88万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638515978","title":"维亚生物(01873)5月26日斥资97.88万港元回购70.85万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638515978","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638515978?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:37","pubTimestamp":1779791865,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维亚生物(01873)发布公告，于2026年5月26日斥资97.88万港元回购70.85万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维亚生物(01873)5月26日斥资97.88万港元回购70.85万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","01873","BK1576"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivabiotech.com","stockEarnings":[{"period":"1week","weight":-0.0873},{"period":"1month","weight":-0.2722},{"period":"3month","weight":-0.5208},{"period":"6month","weight":-0.4072},{"period":"1year","weight":-0.3681},{"period":"ytd","weight":-0.3611}],"compareEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0604},{"period":"1year","weight":0.0101},{"period":"ytd","weight":-0.0477}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"维亚生物科技控股集团是一家投资控股公司。该公司有两个分部。药物发现服务分部提供就临床前创新药物开发向生物科技及制药客户提供基于结构的药物发现服务。同研发生产组织务（CDMO）及商业化服务分部从事小分子原料药及中间体的合同研发生产服务以及买卖原料药、中间体及制剂。该公司主要在美国、中国、欧洲和其他地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.080145},{"month":2,"riseRate":0.285714,"avgChangeRate":0.018359},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.001599},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.030961},{"month":5,"riseRate":0.571429,"avgChangeRate":0.174922},{"month":6,"riseRate":0.25,"avgChangeRate":-0.040924},{"month":7,"riseRate":0.714286,"avgChangeRate":0.010126},{"month":8,"riseRate":0.428571,"avgChangeRate":0.041644},{"month":9,"riseRate":0.285714,"avgChangeRate":0.021762},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.044725},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.040545},{"month":12,"riseRate":0.571429,"avgChangeRate":0.026236}],"exchange":"SEHK","name":"维亚生物","nameEN":"VIVA BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维亚生物(01873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维亚生物,01873,维亚生物股票,维亚生物股票老虎,维亚生物股票老虎国际,维亚生物行情,维亚生物股票行情,维亚生物股价,维亚生物股市,维亚生物股票价格,维亚生物股票交易,维亚生物股票购买,维亚生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维亚生物(01873)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维亚生物(01873)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}